# Tahir Amin

Top Podcast-Folgen
Aktualisiert:

Here’s How We Can Make Medicines More Affordable

Listen to story:https://ia903107.us.archive.org/5/items/2026-05-26-RUWS/2026_05_26_Tahir_Amin.mp3 Download: mp3 (Duration: 20:27) FEATURING TAHIR AMIN - The US Council of Economic Advisers this month released a report assessing consumer prices for pharmaceuticals and co…

097: Pharma Monopoly: The Battle For The Future of Medicines: A Conversation With Tahir Amin

Hello! In this week's episode I am joined by Tahir Amin to discuss his most recent book Pharma Monopoly: The Battle for the Future of Medicines. This book is co-authored with Rohit Malpani. Tahir Amin is a founder and CEO of the Initiative for Medicines, Access & Knowledge (I-MAK). He has spent ov…

Tahir Amin Interview Episode 684

In this episode, I'm joined by global health advocate, founder and CEO of the Initiative for Medicines, Access, and Knowledge (I-MAK), and author Tahir Amin to discuss his groundbreaking book Pharma Monopoly: The Battle for the Future of Medicines. Drawing on decades of work challenging pharmaceu…

The Generics Bulletin Podcast: Probing The Patent Monopoly With I-MAK’s Tahir Amin

The Generics Bulletin Podcast: Probing The Patent Monopoly With I-MAK’s Tahir Amin Description: Generics Bulletin senior reporter Urtė Fultinavičiūtė talks to Tahir Amin, co-founder and CEO of I-MAK, about the current intellectual property system that curtails off-patent drug competition and globa…

The Generics Bulletin Podcast: Probing The Patent Monopoly With I-MAK’s Tahir Amin

The Generics Bulletin Podcast: Probing The Patent Monopoly With I-MAK’s Tahir Amin Description: Generics Bulletin senior reporter Urtė Fultinavičiūtė talks to Tahir Amin, co-founder and CEO of I-MAK, about the current intellectual property system that curtails off-patent drug competition and globa…

Medicine's Monopoly Problem

Episode Summary Tahir Amin started out wanting to play professional football in England. He found law instead, and specifically intellectual property law in the early 1990s, when the field was still new enough to feel cutting edge. After a decade of commercial IP practice in the UK and the US, he m…

How the US patent system keeps drug prices high

Americans pay roughly three times as much for prescription meds as people in other wealthy nations. But why? Tahir Amin argues it’s largely to do with how our patent systems work. He’s been on both sides of the issue: He spent a decade as an intellectual property lawyer, helping corporations use p…

Pharma Monopoly: The Battle for the Future of Medicines w/ Tahir Amin

👉 Pitch in on Patreon and fuel the future of free-thinking conversations. https://www.patreon.com/parallaxviews Also visit our returning sponsor Mike Swanson's Wall Street Window for the best financial and trading newsletter around: https://wallstreetwindow.com/ On this edition of Parallax View…

Mostly Economics Podcast #44: How Patents Made Our Medicine Cost More with Tahir Amin

On this episode of Mostly Economics, Dean Baker talks with Tahir Amin, co-founder and CEO of I-MAK and co-author of Pharma Monopoly, about how drug patents drove up prices and blocked vaccines during the pandemic. Find out how a drug like Humira made $114 billion off patent monopolies and more. -- …

Challenges in Global Access to Life-Saving Medications and Vaccines

About this episode: During the recent pandemic, low-income countries struggled to access the COVID-19 vaccine, despite a global framework that had been established for this purpose. In this episode: Tahir Amin, a leader in the access to medicines movement, shares his perspective on what failed duri…